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Summary
Since the first clinical use of extracorporeal circulation in
the last century by John Gibbon and the first successful
mechanical support of the left ventricular function by
Forest Dodrill, the progress of techniques and technologies
has helped to develop minimised systems for extracorpor-
eal circulatory and respiratory support. However, the fact is
that, despite the advanced technologies used for extracor-
poreal support, successful application in order to be benefit
a critically ill population requires highly trained and skilled
teams. Application of these highly sophisticated techniques
in life-saving situations inside and/or outside the operating
room is a procedure with certain pitfalls and dangers.
The aim of this review is to provide a short overview of the
technical aspects of extracorporeal circulation, with a look
at the recent literature and clinical experiences focusing on
technical as well surgical considerations regarding the ur-
gent and/or emergent usage of a central as well as peripher-
al extracorporeal system.
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Introduction
Since the first clinical use of extracorporeal circulation in
the last century [1] by John Gibbon and the first success-
ful mechanical support of the left ventricular function by
Forest Dodrill [2], the progress of techniques and technolo-
gies has helped to develop minimised systems for extracor-
poreal circulatory and respiratory support.
Extracorporeal life support (ECLS) is a therapeutic option
used in patients with cardiac, respiratory or cardiorespirat-
ory failure that is refractory to conservative therapy mod-
alities [3, 4]. This therapy option is meant to be a bridge
to organ or organ system recovery, to definitive decisions
in life-threatening situations, to long-term support device
implantation, and to heart, lung-heart and lung transplanta-
tion.
Nowadays, two ECLS modalities are well established, ven-
ovenous (VV) and venoarterial (VA) ECLS. ECLS is basic-
ally a modification of cardiopulmonary bypass where the
most essential part of the circuit is an oxygenator with or
without a heat exchanger. The venous blood is removed
from the central venous system either by cannulation of
a peripheral great vein (femoral vein, external jugular and
subclavian vein) or by inserting the venous cannula into the
right atrium. After the venous blood is oxygenated and car-
bon dioxide is removed the blood is returned to the body
via a peripheral path through cannulation of the femoral
artery, or by a central path where the arterial cannula may
be inserted directly into the ascending aorta or into the sub-
clavian artery.
It should be noted that the optional modalities of VA ECLS
are extracorporeal membrane oxygenator (ECMO) and left
ventricular assist devices (VADs), where the VAD stands
for haemodynamic support by a centrifugal pump, without
inclusion of an oxygenator in the circuit. Although the re-
cent re-interest in ECLS techniques, especially by success-
ful application of VV ECLS in the treatment of an H1N1
influenza pandemic [5], there is a net lack of evidence
regarding its routine application. There are a number of
Figure 1
Configuration of the venovenous extracorpareal life support
cannulation. (A) Femoroatrial cannulation, where the cannula
positioned in the femoral vein serves as a drainage device and is
placed with its tip 5 to 10 cm inferior to the angle between the
inferior vena cava and right atrium. The oxygenated blood is
returned via a cannula positioned in the internal jugular vein. (B)
Femorofemoral cannulation. The drainage cannula is positioned
with its tip about 5 to 10 cm below the junction between the inferior
vena cava and right atrium. The oxygenated blood is delivered by
the other cannula that has its tip positioned in the right atrium. (C)
Single venovenous cannulation, here the drainage segments are
positioned in the superior and inferior vena cava. The oxygenated
blood is delivered in the right atrium just in front of the tricuspid
valve.
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factors that limit more frequent usage of ECLS circuits, in-
cluding correct patient selection, appropriate strategies, ap-
propriate technical aspects of ECLS maintenance and ini-
tialisation. All of these factors put a limit on conducting
well-controlled clinical trials. The aim of this review is to
analyse the pitfalls of recently available ECLS modalities,
focusing on technical aspects and the most frequent com-
plications.
Extracorporeal support for respiratory
failure
VV ECLS is used for severe acute respiratory distress syn-
drome (ARDS) refractory to conservative therapy modal-
ities. The advantage of the VV ECLS in ARDS over VA
ECLS is that it may be employed via peripheral cannula-
tion, and does not result in upper body hypoxaemia. Up-
per body hypoxaemia is a well-known phenomenon that
may occur in patients with respiratory failure and preserved
heart function who are supported with peripheral VA
ECLS; this phenomenon is described below.
VV ECLS does not provide any haemodynamic support;
however, with successful oxygenation and/or carbon diox-
ide extraction, the ventilation setting may be reduced down
to rest levels, i.e., a peak inspiratory pressure of 20 cm
H2O, end expiratory pressure 10 cm H2O, rate 10 breaths
per minute and FiO2 30%. This may augment the heart
function in two ways. First, with better blood oxygenation,
a sufficient amount of oxygen is delivered to the heart, and
second, the reduced intrathoracic pressure contributes to
better heart function. In the CESAR study [6] in 2009 the
treatment of H1N1influenza with VV ECMO contributed
to excellent results, with reported survival of 63% versus
47% for those not treated with VV ECMO. Notably, 28
cases out of 57 allocated to the VV ECMO were at the time
of device induction in multiorgan failure and sepsis, having
low heart output. Less than 10% of the cases needed VA
ECMO support because of haemodynamic instability [6].
To date, two modalities of VV ECLS for lung support
have been established in daily clinical practice: (1.) double
VV ECLS cannulation and (2.) single VV ECLS cannula-
tion techniques. Both support modalities are introduced and
analysed below.
Double venovenous cannulation for
pulmonary ECLS
Two venous cannulas are used, such that deoxygenated
blood is drained from a large central vein, in the majority
of cases the inferior vena cava (IVC), and the oxygenated
blood is delivered to the right atrium (RA). According to
the cannula positioning two further modalities can be dif-
ferentiated: femoroatrial and femorofemoral cannulation.
Before going into the details of support for the two VV
ECSL modalities, it has to be mentioned that independently
from support modality, the flow in the circuit depends on
the inserted drainage cannula size. This is limited by target
vessel size, and for adults the size of commercially avail-
able venous femoral cannulas (Bio-Medicus Multi Stage
Femoral, Medtronic Inc. USA) ranges between 27F to 29F,
with which a maximal circuit flow of around 5 l/min may
be achieved. The standard Bio-Medicus wire-reinforced
multiorifice cannula is usually positioned with its tip in
the right atrium or just underneath it, and consequently all
the blood drained inferior to this level has to travel from
the inferior body along the IVC to its junction with the
RA. Only here, where the multiporus part of the cannula
is positioned, may the blood enter the device [7]. Unfor-
tunately, in this way only 70% to 80% of the theoretical
target pump-flow can be achieved [8]. In contrast, a self-
expanding device (SmartCannula, Lausanne, Switzerland),
that has a multiporous grid-like structure and adapts its dia-
meter to the natural vascular diameter in a self-expanding
way, drains the IVC side branches in a direct way. As such,
the flow achieved may be 40% higher than with a wire-re-
inforced device [9, 10].
In current routine clinical practice, however, self-expand-
ing cannulas have not gained the place that might be expec-
ted, and at a majority of centres wire-reinforced multipor-
ous devices are used. There usage is thus described below.
Femorofemoral cannulation for ECLS: Here two cannulas
are inserted into the contralateral femoral veins. The drain-
age cannula is positioned with its tip about 5 to 10 cm be-
low the junction between the IVC and RA. The oxygenated
blood is delivered by the other cannula, which has its tip
positioned in the right atrium (figs 1 and 2).
Femoroatrial cannulation for ECLS: Here also, two can-
nulas are inserted into the central venous target vessel, one
in the femoral vein and a second in the internal jugular
vein. The cannula positioned in the femoral vein serves as a
drainage device and is placed with its tip 5 to 10 cm inferi-
or at the angle between the IVC and RA. The oxygenated
blood is returned via a cannula positioned in the internal
jugular vein (IJ), and the tip of this device is placed in the
right atrium (figs 1 and 2).
In both cannulation modalities it is more than obvious that
the correct tip position has to be verified. This is in order
to avoid central vessel and/or heart structure damage and
to minimise the recirculation phenomenon. In VV ECLS,
ideally all the blood from the inflow cannula should pass
through the tricuspid valve into the pulmonary circulation.
From here on the oxygenated blood is distributed into the
systemic blood stream through ejection by the left vent-
ricle. However, the blood from the inflow cannula posi-
tioned in the right atrium does not entirely enter the pul-
monary circulation. Part of it enters the drainage cannula
that is placed just inferior to the angle between the IVC
and RA, and thus does not contribute to systemic oxygen-
ation. This is called the “recirculation” phenomenon. Be-
cause of the recirculation phenomenon, in a case when the
lung does not contribute to oxygenation it is not always
possible to achieve the normal arterial oxygen saturation
(SaO2). The commonly accepted target for SaO2 is 85% to
92%. Theoretically, if the recirculation is held at minimal
amount, then with 70% of normal cardiac output this target
of SaO2 may be achieved. It is easy to understand that pa-
tient conditions such as intravascular volume load, patient
position, pump flow and the position of the cannulas are
the most important factors that influence the grade of recir-
culation. The recirculation phenomenon may be assessed
at the patient’s bedside by comparing the oxygen satura-
tion at the venous side of the oxygenator with SaO2. A
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high preoxygenantor oxygen saturation SaO2 (>75%) and
low SaO2 (<85%) is indicating a significant amount of oxy-
genated blood escaping the pulmonary circulation. In con-
trast, if the preoxygenator oxygen saturation is low (<60%)
and the SaO2 is also low (<85%), this would mean that
either the patient’s cardiac output is high or the pump flow
on ECLS is too low. It is important that if recirculation
is suspected, the positions of the cannulas be verified. A
simple chest anterioposterior image provides basic inform-
ation about cannula placement; however, thransoesophagi-
al echo (TEE) is a more accurate method. Clearly the reper-
fusion phenomenon may be reduced by correct positioning
of the cannulas, and this may be done under TEE or flu-
oroscopic control. It seems that TEE echocardiography is
not entirely accurate, as only the tip of the cannula may be
visualised, and not the whole run of the device inside the
vascular bed [12]. The details of implantation will be ad-
dressed below.
The major disadvantage, besides the recirculation phenom-
ena, of the double cannula venous system is post-interven-
tional patient management. Since lung function recovery,
for example in a bridge to transplant, usually takes 1 to
3 weeks or even more, a bicaval VV ECLS requires bed
rest and patients in most circumstances remain sedated and
mechanically ventilated, with all its associated inconveni-
ences and complications [12].
Single venovenous cannula for
pulmonary ECLS
The aforementioned drawbacks of double venous cannula
ECSL were addressed by introduction of the single catheter
venovenous ECLS (Avalon© Cannula, Avalon Laborator-
ies, Grand Rapids, Michigan, USA). Although the double
venovenous ECLS strategy was adopted and is routinely
used as a preferred modality for severe pulmonary refract-
ory failure, the Avalon© cannula should be considered as
a first-line strategy for acute respiratory failure and as a
Figure 2
Different types of cannulation for venovenous and venoarterial
cannulation. (A) Femorofemoral venovenous extracorporeal life
support (VV ECLS) cannulation modality, with drainage cannula just
underneath of the junction between the inferior vena cava and right
atrium. The inflow cannula is positioned in the right atrium. (B)
Venoatrial VV ECLS cannulation modality, where the drainage
cannula is positioned just underneath the right atrium. The inflow
cannula is placed via the internal jugular vein with its tip just in front
of the tricuspid valve. (C) Standard central cannulation for ECLS,
here the drainage device is depicted positioned in the femoral vein.
Of note is that from the aspect of support this does not show any
difference compared with the device being in right atrium. (D)
Femorofemoral AV ECLS cannulation modality, with drainage
device in the inferior vena cava and the inflow cannula in
contralateral femoral artery.
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bridge to transplantation [14, 15]. Patients may be ex-
tubated, mobilised and transferred to normal nursing
wards, which facilitates recovery, lung toilet and outcome
following lung transplantation [14].
The single venovenous cannula modality of pulmonary
ECLS is comprised of one single catheter inserted via the
right internal jugular vein (IJV); venous drainage and de-
livery of oxygenated blood is performed with one single
double-lumen device (fig. 1). The Avalon© cannula is a
wire-reinforced device with two separate compartments,
one for venous drainage and the other for delivery of the
oxygenated blood. The delivery segment of the cannula is
positioned between the two drainage parts at the inferior
third of the device (fig. 1). According to the device struc-
ture, the two drainage segments should be positioned in the
superior as well in the inferior vena cava, where the deoxy-
genated blood is drained from the inferior as well from the
upper body and is delivered to the oxygenator. The middle
segment that is responsible for delivery of the oxygenated
blood has to be placed in the right atrium just in front of
the tricuspid valve [12]. Positioning of the inflow part of
the Avalon cannula in front of the tricuspid valve may be
done only by using TEE. Since TEE is obviously an essen-
tial fragment in successful implantation, in many centres it
was adopted as the sole medium for Avalon© cannula im-
plantation. Unfortunately, TEE as implantation guide may
not clearly exclude the looping effect during the position-
ing of the device [12, 16] and as such does not guarantee a
100% safe implantation.
The commercially available insertion of the Avalon© can-
nula kit, has a flexible “J tip”, 20 cm, 0.038 inch radi-
opaque guidewire that is soft and flexible. The soft nature
of the wire provides minimal risk of perforation of the heart
and/or of the surrounding venous structure, but thus has an
affinity to flip out of the correct position and can loop up
into the right ventricle or to the right atrium [12, 18, 19].
An undetected looping of the wire, which is the case when
only TEE is used as implantation guidance, can direct the
dilatator and/or the cannula toward the anterior wall of the
right ventricle or toward the lateral wall of the right atrium,
with fatal consequences [12, 18, 19]. The incidence of right
heart cavity perforation varies between 5% and 15% [15,
18].
To avoid this complication, two strategies may be adopted.
If the patient can be transferred into the operating theatre,
fluoroscopy can be used as control for cannula positioning
in the axis superior vena cava, right atrium and inferior
vena cava. In this way, the looping effect can be detected
early and safe cannula implantation is assured [12, 15].
In cases when patient transport is not possible, at the bed-
side, owing to cardiorespiratory instability, salvage VV
ECLS is required. In these situations TEE is the only pos-
sible guide tool. It is advised that after the flexible wire is
implanted a Berenstein directional catheter be placed over
the wire. In the next step, the Avalon© wire is removed and
a 180 cm, 0.0035” Amplatz Super Stiff guide-wire (Bo-
ston Scientific, Natic, MA) is passed in the IVC and subse-
quently the Avalon© cannula is implanted [12, 17].
Extracorporeal support for cardiac
failure
Several options exist for circulatory support in cardiac fail-
ure. In an acutely decompensated patient who is under
mechanical and/or pharmacological resuscitation as tem-
porary support, ECLS can be a bridge to decision making
that may best serve the patient and is the most appropriate
therapy strategy. To date there is no evidence comparing
different short-term mechanical support devices such as
temporary ventricular assist devices, and intra-aortic coun-
terpulsation to AV ECLS for refractory cardiac failure.
However, it seems that AV ECLS is the therapy of choice
in this setting [19, 20].
The indications for AV ECLS are as follows: unsuccessful
weaning from cardiopulmonary bypass, acute myocardial
infarction, ischaemic cardiomyopathy, acute myocarditis,
acute cardiorespiratory failure (i.e., central pulmonary em-
bolism) and post-partum cardiomyopathy, including acute
organ failure following heart transplantation. Successful
support as a bridge to heart transplantation has been de-
scribed as well as support until re-transplantation in the
case of refractory allograft failure [21–23]. The reported
survival varies between 20% to 60% at experienced centres
and is largely dependent on indication, patient selection
and mode of employment of this support modality [23].
Basically there are two modalities of the VA ECLS config-
uration, a central and peripheral cannulation mode.
Central cannulation for cardiac ECLS
In most instances, central ECLS is performed in theatre in
the open chest, when weaning off the cardiopulmonary by-
pass has failed (fig. 2). Rarely, primary sternotomy is per-
formed to establish VA support. In the open chest, the can-
nulas are inserted into the ascending aorta for delivery of
the oxygen and venous drainage is performed by cannulas
positioned in the right atrium. This modality of ECLS al-
lows excellent flow conditions, since the venous cannula
inserted is not size-restricted (as in the case of a femoral
cannulation) and sufficient pump flow for a large body sur-
face area (>2.0 m2) may be achieved. A second advantage
of the central perfusion modality is that the central position
of the inflow cannula provides an antegrade inlet of oxy-
genated blood to the aortic arch and its vessels, coronary
arteries and other parts of the body. One of the major draw-
backs of the central cannulation is that the cannula inser-
tions require a sternotomy and subsequently an open chest.
This open chest situation is prone to the very important
considerations of bleeding, repeated open wound dressings
and to infections. However, devices do exist, such as the
Abiomed central cannula (Abiomed, Cardiovascular Inc,
Danvers, MA) that may be tunnelled through the abdomin-
al wall, allowing closure of the chest.
Peripheral cannulation for cardiac ECLS
The most common installation of peripheral ECLS is in-
sertion of cannulas in femoral vessels (fig. 2), with a ven-
ous cannula inserted into the femoral vein and the arterial
cannula into the ispsilateral or contralateral femoral artery.
Peripheral ECLS may be considered as rescue option for
those cases where the myocardial depression is profound or
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if the conditions for the cardiac or cardio/respiratory failure
are unclear and conditions such as myocarditis are likely. In
such a cases, with multiorgan failure and severe coagulo-
pathy, the institution of ECLS may be considered as bridge
to decision or even as a successful therapy modality [24].
This is a result of the quick, relatively simple bedside can-
nulation procedure and installation of full cardiorespiratory
support. The major drawback of femoral cannulation is the
femoral venous access. This limits the size of the device
used, which, as mentioned before, is the major drawback
for the flow support achieved. To avoid this, a second ven-
ous drainage cannula may be installed in a large vein of the
upper body, for example through cannulation of the sub-
clavian vein [24]. The bleeding from the cannulation site
may be as high as 10% [23] requiring surgical revision, and
the distal limb ischaemia ranges between 13% and 15%
[13]. In contrast to central ECLS, peripheral support from
femoral vessels leads to the blood mixing in the arch and
ascending aorta. In the case of respiratory failure the poorly
oxygenated blood will be pumped by the heart to the coron-
ary arteries and the vessels of the arch, while the ECMO
circuit is supplying the well-oxygenated blood to the distal
segment of the arch. This may result in hypo-oxygenation
of the upper body segment as well of the heart. For this
reason monitoring the oxygen saturation at the radial artery
is necessary, and additionally the ventilation support may
not be reduced to rest levels, in order to try to keep the oxy-
gen saturation of blood ejected from the left ventricle above
90%.
Cannulation technique and pitfalls
The complications related to ECLS in adults are summar-
ised in table 1. Although in many cases the establishment
of ECLS circulation is performed in extreme situations,
aseptic technique during cannula implantation has to be
respected. This includes full sterile preparation, draping,
etc., independently of whether the ECLS is performed in
theatre, or at the patient’s bedside in the intensive care unit
or in the emergency room. Introduction by the Seldinger
technique is well-established, and the identification and
puncture of the femoral vessels should be done by use of
femoral utrasonography. However, in a salvage situation
this is not always available. In this case, the vessels may
be punctured directly; if after a 3-minute attempt this it is
not successful [25], then surgical exposure of the femoral
Table 1: Complications associated with extracorporeal life support in
adults.
Complication Incidence (%)
Limb ischaemia and amputation of cannulised
limb
10 to 25
Haemorrhage associated with the
anticoagulation regime
5 to 70
Infections 15 to 50
Neurological events 13 to 33
Mechanical complication associated with the
circuit
3 to 22
Inflammation and coagulopathy associated with
the circuit
5 to 8
Damage to the heart and surrounding vessels 5 to 15
Renal failure 30 to 50
vessels should be performed. Afterwards, the anterior ves-
sel wall is identified and double purse-string sutures (with
proline 5-0) are placed to secure the cannula position and
to avoid later insertion-site bleeding. In establishment of
VA ECLS, in the first attempt the femoral artery should
be punctured. After the vessels are successfully punctured
and a guide viewer is placed in the femoral artery, heparin
(5,000 IU) is given intravenously, aiming for an activated
coagulation time (ACT) of above 180 seconds. It should be
noted that the guidewire should run smoothly without res-
istance, and if there is any resistance, we suggest pulling
back the wire for a few centimetres and advancing it with a
gentle pushing movement into the vessels. The position of
the wire may be achieved by rotation of the wire between
two fingers. In the next step, the dilatators are advanced
into the femoral artery, and at this point we have to be
aware that advancing the dilatator may bend the guidewire.
If this occurs, subsequent steps for the cannula implanta-
tion are almost always impossible and the guidewire has to
be changed. To avoid this we propose simultaneous inward
movement of the dilatator/cannula while the wire is pulled
smoothly; in doing so we get direct feedback regarding the
gliding of the wire. Finally, after the arterial cannula is in
situ the guidewire may be removed. This procedure is re-
peated for the introduction of the venous cannula. Here the
positioning of the guidewire in the inferior vena cava as
well the position of the venous cannula has to be confirmed
and checked during the procedure.
The positioning of the arterial cannula in the femoral artery
bears the risk of leg ischaemia, which ranges between 10%
to 15% [23]. Dual flow arterial cannulas for VA ECLS
with sufficient distal flow for the leg have been developed,
but unfortunately have never been commercially available
[26]. Commonly, there are two strategies that are adopted
to avoid leg ischaemia. One is the percutaneous puncture of
the distal femoral artery by 10F or 12F cannulas. Normally,
the femoral artery is punctured at the mid-thigh under ul-
trasound guidance, before the venous device is inserted.
However, sometimes the percutaneous puncture of the
distal femoral artery is not easy. Some institutes use a semi-
Seldinger technique distal and proximal to arterial cannula
implantation. Here the cannulas are implanted after the sur-
gical exposure of the femoral arteries is completed.
Conclusion
ECLS is a potentially lifesaving procedure in pulmonary,
cardiac and cardiopulmonary failure. The usage and the
indication for this therapy modality have widened in the
past several years, especially after data were provided for
VV ECLS in treatment of influenza H1N1 pulmonary fail-
ure, which showed benefit over conservative treatment. Al-
though the results for ECLS in cases with pulmonary dys-
function are good, the outcomes in cardiac failure are still
modest. At the same time we should remember that intro-
duction of ECLS is invasive, and allied to many complica-
tions and pitfalls. From this point of view, it is very import-
ant to provide a team approach with good communication
together with excellent teamwork among intensivists, car-
diac anaesthesiologists, surgeons, perfusionists and other
personnel involved.
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Figures (large format)
Figure 1
Configuration of the venovenous extracorpareal life support cannulation. (A) Femoroatrial cannulation, where the cannula positioned in the
femoral vein serves as a drainage device and is placed with its tip 5 to 10 cm inferior to the angle between the inferior vena cava and right
atrium. The oxygenated blood is returned via a cannula positioned in the internal jugular vein. (B) Femorofemoral cannulation. The drainage
cannula is positioned with its tip about 5 to 10 cm below the junction between the inferior vena cava and right atrium. The oxygenated blood is
delivered by the other cannula that has its tip positioned in the right atrium. (C) Single venovenous cannulation, here the drainage segments are
positioned in the superior and inferior vena cava. The oxygenated blood is delivered in the right atrium just in front of the tricuspid valve.
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Figure 2
Different types of cannulation for venovenous and venoarterial cannulation. (A) Femorofemoral venovenous extracorporeal life support (VV
ECLS) cannulation modality, with drainage cannula just underneath of the junction between the inferior vena cava and right atrium. The inflow
cannula is positioned in the right atrium. (B) Venoatrial VV ECLS cannulation modality, where the drainage cannula is positioned just underneath
the right atrium. The inflow cannula is placed via the internal jugular vein with its tip just in front of the tricuspid valve. (C) Standard central
cannulation for ECLS, here the drainage device is depicted positioned in the femoral vein. Of note is that from the aspect of support this does
not show any difference compared with the device being in right atrium. (D) Femorofemoral AV ECLS cannulation modality, with drainage device
in the inferior vena cava and the inflow cannula in contralateral femoral artery.
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